Completed PHASE2 INTERVENTIONAL 2-arm NCT01461590

Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia (Tx30)

Phase II Trial of Transfusion Volumes in Children With Acute Severe Anaemia

Sponsor: Imperial College London

Interventions Whole blood

Updated 5 times since 2017 Last updated: Mar 31, 2015 Started: Oct 31, 2011 Primary completion: Jan 31, 2012 Completion: Jan 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01461590, this PHASE2 trial focuses on Severe Anaemia and remains completed. Sponsored by Imperial College London, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Imperial College London
Prof Kathryn Maitland

Data source: KEMRI-Wellcome Trust Collaborative Research Program

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mbale, Uganda
• Soroti, Uganda